DE3490527C2 - - Google Patents

Info

Publication number
DE3490527C2
DE3490527C2 DE3490527A DE3490527A DE3490527C2 DE 3490527 C2 DE3490527 C2 DE 3490527C2 DE 3490527 A DE3490527 A DE 3490527A DE 3490527 A DE3490527 A DE 3490527A DE 3490527 C2 DE3490527 C2 DE 3490527C2
Authority
DE
Germany
Prior art keywords
cells
monoclonal antibody
atl
recognizes
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3490527A
Other languages
German (de)
English (en)
Other versions
DE3490527T (de
Inventor
Ueda Nagoya Aichi Jp Ryuzo
Ohta Nagoya Aichi Jp Kazuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE3490527C2 publication Critical patent/DE3490527C2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56972—White blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/112—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3061—Blood cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE3490527A 1983-11-09 1984-03-23 Expired - Lifetime DE3490527C2 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58210381A JPS60231699A (ja) 1983-11-09 1983-11-09 正常及び悪性ヒト造血器細胞に対するモノクローナル抗体

Publications (1)

Publication Number Publication Date
DE3490527C2 true DE3490527C2 (enExample) 1993-08-26

Family

ID=16588395

Family Applications (2)

Application Number Title Priority Date Filing Date
DE3490527A Expired - Lifetime DE3490527C2 (enExample) 1983-11-09 1984-03-23
DE19843490527 Pending DE3490527T (de) 1983-11-09 1984-03-23 Neue monoklonale Antikörper

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19843490527 Pending DE3490527T (de) 1983-11-09 1984-03-23 Neue monoklonale Antikörper

Country Status (5)

Country Link
US (1) US4855235A (enExample)
JP (1) JPS60231699A (enExample)
DE (2) DE3490527C2 (enExample)
GB (1) GB2163178B (enExample)
WO (1) WO1985002188A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0325489B1 (en) * 1988-01-21 1994-01-19 Becton, Dickinson and Company Leu 23: Monoclonal antibody for monitoring leukocyte activation
FR2634126B1 (fr) * 1988-07-13 1992-04-17 Unicet Laboratoires Anticorps monoclonal specifique pour un antigene de surface des cellules b activees et/ou des cellules t transformees par l'htlv-i, lignee de cellules d'hybridomes produisant cet anticorps, procede pour la detection de cellules t transformees par l'htlv-i et/ou de cellules b activees
ATE516354T1 (de) * 1997-05-15 2011-07-15 Genentech Inc Apo-2-rezeptor
US6342369B1 (en) * 1997-05-15 2002-01-29 Genentech, Inc. Apo-2-receptor
US20100152426A1 (en) * 1997-05-15 2010-06-17 Ashkenazi Avi J Apo-2 receptor fusion proteins
US6252050B1 (en) * 1998-06-12 2001-06-26 Genentech, Inc. Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
JP2002517223A (ja) * 1998-06-12 2002-06-18 ジェネンテック・インコーポレーテッド モノクローナル抗体、交叉反応性抗体およびそれを生成する方法
AUPR177400A0 (en) * 2000-11-29 2000-12-21 Cancerprobe Pty Ltd Probes for identifying cancer-specific antigens

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017381A2 (en) * 1979-03-20 1980-10-15 Ortho Pharmaceutical Corporation Monoclonal antibody to human T cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it
EP0018794A2 (en) * 1979-04-26 1980-11-12 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4515894A (en) * 1979-03-20 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human T cells
US4515895A (en) * 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human helper T cells
US4515893A (en) * 1979-04-26 1985-05-07 Ortho Pharmaceutical Corporation Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells
US4361549A (en) * 1979-04-26 1982-11-30 Ortho Pharmaceutical Corporation Complement-fixing monoclonal antibody to human T cells, and methods of preparing same
US4637983A (en) * 1979-10-09 1987-01-20 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to human cytotoxic and suppressor T cells, antibody, and methods
US4364933A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human thymocyte antigen and methods of preparing same
US4364934A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human early thymocyte antigen and methods for preparing same
US4364935A (en) * 1979-12-04 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human prothymocyte antigen and methods of preparing same
US4614720A (en) * 1980-01-08 1986-09-30 Ortho Pharmaceutical Corporation Hybrid cell line for producing monoclonal antibody to a human T cell antigen, antibody, and methods
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
DE3177276D1 (de) * 1980-04-11 1992-04-23 Celltech Ltd Monoklonale antikoerper.
IL62965A0 (en) * 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
AU530649B2 (en) * 1981-01-28 1983-07-21 Coats Patons Plc Method of manufacturing monoclonal antibodies and capable of manufacturing such antibodies
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4550086A (en) * 1983-02-16 1985-10-29 Dana-Farber Cancer Institute, Inc. Monoclonal antibodies that recognize human T cells
US4642925A (en) * 1985-11-22 1987-02-17 International Radiology Systems, Inc. X-ray film mount

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017381A2 (en) * 1979-03-20 1980-10-15 Ortho Pharmaceutical Corporation Monoclonal antibody to human T cells, method for preparing it, hybrid cell line producing it, therapeutic composition comprising it and diagnostic method using it
EP0018794A2 (en) * 1979-04-26 1980-11-12 Ortho Pharmaceutical Corporation Monoclonal antibody to human helper T cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Blood, Vol. 60, Nr. 1, Juli 1982, S. 1-19 *

Also Published As

Publication number Publication date
US4855235A (en) 1989-08-08
GB2163178B (en) 1987-10-14
GB8517441D0 (en) 1985-08-14
DE3490527T (de) 1985-11-14
JPH0340B2 (enExample) 1991-01-07
GB2163178A (en) 1986-02-19
JPS60231699A (ja) 1985-11-18
WO1985002188A1 (fr) 1985-05-23

Similar Documents

Publication Publication Date Title
DE3883803T2 (de) Monoklonale Antikörper gegen melanoma-assoziierte Antigene, Hybridzellinien, die diese Antikörper produzieren, und ihre Verwendung.
EP0260610B1 (de) Monoklonale Antikörper gegen humanen Tumonekrosefaktor (TNF) und deren Verwendung
DE69028684T2 (de) Gegen die beta-kette des leukozyten-adhäsions-rezeptors gerichtete monoklonale antikörper, verfahren zu ihrer herstellung und ihre verwendung
DE69330643T2 (de) Monoklonaler antikörper, welcher spezifisch an vaskularisiertes tumorendothelium bindet und verwendungen davon
AT400577B (de) Verfahren zur herstellung eines monoklonalen antikörpers und verfahren zum nachweisen von malignen zellen
EP0657533A1 (de) Monoklonale Antikörper mit hoher Zytotoxizität gegen humanes CD16-Antigen, sowie bispezifische monoklonale Antikörper unter Verwendung derartiger monoklonaler Antikörper und des CD-30-HRS-3-Antikorpers
EP0794195A2 (de) Antikörper BV10A4H2
DE69031313T2 (de) Monoklonaler antikörper, der zwischen helfer-inducer- und supressor-inducer-cd4+lymphozyten unterscheidet
EP0531300A1 (de) Variante cd44-oberflächenproteine, diese kodierende dna-sequenzen, antikörper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie.
DE3346336A1 (de) Verfahren zur herstellung von erythropoetin
DE69911322T2 (de) Monoklonaler antikörper der die oligosaccharide sialinsäure n-glycolierte galactose-glucose auf bösartige tumoren erkennt und zusammensetzungen die dieser enthalten
DE3218312C2 (de) Monoklonale Antikörper, Hybridoma-Zellklone, Verfahren zu ihrer Herstellung und ihre Verwendung zur Erkennung von Brustkrebs und maligner Lymphogranulomatose
DE3687014T2 (de) Zum erkennen von tumoren faehige klonierte t-zelle und ein t-zellen-antigenrezeptor.
DE3490527C2 (enExample)
DE3939706C1 (enExample)
DE3689948T2 (de) Monoklonale antikörper und testverfahren.
EP0889125B1 (de) Monoklonaler Antikörper 4G8B4B12 gegen humanes FLT3/FLK2
EP0340604A2 (de) Monoklonaler Antikörper und seine Verwendung
DE69434024T2 (de) Auf humanen cortikalen thymozyten exprimierte oberflächenproteine und ihre verwendung
DE68914016T2 (de) Identifizierung von NK-Zellen und cytotoxische T-Lymphozyten.
DE3688638T2 (de) Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs.
DE3785795T2 (de) Monoklonale anti-menschliche magenkrebs-antikoerper.
EP0090343A2 (de) Zell-Hybrid, Verfahren zu seiner Herstellung sowie seine Verwendung
DE69331942T2 (de) Verwendung und herstellung eines metastaseninhibitors bzw. eines zelladhäsionsinhibitors enthaltend einen antikörper
DE3785637T2 (de) Monoklonale antikoerper gegen menschliche mesotheliale zellen.

Legal Events

Date Code Title Description
8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P.,

8110 Request for examination paragraph 44
8128 New person/name/address of the agent

Representative=s name: TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D

D2 Grant after examination
8364 No opposition during term of opposition